MedTrace Logo

Tailored Approaches to Reduce Distress and Improve Self-Management for Veterans With Diabetes

NCT04587336 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 225

Last updated 2025-05-02

Study results available
· View outcomes & findings →

Summary

Veterans with diabetes may become overwhelmed with the self-management behaviors needed to maintain optimal health. Veterans may experience diabetes distress (DD), a concept distinct from depression, due the amount and frequency of these behaviors. DD negatively influences the Veteran's engagement in self-management and subsequent HbA1c levels. Previous interventions do not tailor T2D self-management information to a Veteran's DD, which may be one reason interventions are ineffective at reducing DD. This proposal examines the impact of correlating factors (e.g., sociodemographic, psychosocial, and environmental) on DD using surveys and semi-structured interviews. This proposal will prepare Allison Lewinski, PhD, MPH, RN for a career as a scientist at VHA focused on developing methods to improve health outcomes among Veterans.

Conditions

  • Diabetes
  • Diabetes Distress
  • Self-Management
  • Veteran

Interventions

BEHAVIORAL

Cognitive Interview

Examine the understanding and interpretation of diabetes distress and the Diabetes Distress Scale in Veterans with T2D.

BEHAVIORAL

Baseline Survey

Examine the association of psychosocial factors (depression, PTSD), environmental factors (finances, support), self-management behaviors, and HbA1c with DD.

BEHAVIORAL

Qualitative Interviews

Describe self-management challenges and preferred learning strategies to inform intervention components and delivery approach for Veterans with T2D.

Sponsors & Collaborators

  • VA Office of Research and Development

    lead FED

Principal Investigators

  • Allison Lewinski, PhD · Durham VA Medical Center, Durham, NC

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-24
Primary Completion
2024-03-31
Completion
2025-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04587336 on ClinicalTrials.gov